Lilly awaits U.K. decision this week on Prozac for children

Eli Lilly will be watching closely this week while British regulators decide whether to make the company's Prozac the first anti-depressant drug approved in the U.K. for children, as it is in the U.S. The U.K. regulators have had their eye on fluoxetine, the generic name of Prozac, for nearly a year as one drug for youths that would not lead them to consider suicide and one in which the benefits outweigh the risks.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX